-+ 0.00%
-+ 0.00%
-+ 0.00%

United Therapeutics CEO Chairperson Martine Rothblatt disposes of 9,500 shares worth $5.03 million

PUBT·08/10/2026 20:41:55
Listen to the news
United Therapeutics CEO Chairperson Martine Rothblatt disposes of 9,500 shares worth $5.03 million
  • United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at $135.42.
  • A family trust sold 9,500 shares at weighted average prices of about $525.29 to $540.32 on Aug. 7, 2026.
  • The trust ended with 324,443 shares of common stock, down from 333,943 shares before the transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000116), on August 10, 2026, and is solely responsible for the information contained therein.